Ramucirumab in combination with dacarbazine in patients with progressive well-differentiated metastatic pancreatic neuroendocrine tumors (RamuNET): study protocol for a multicenter single-arm trial.
BMC Cancer
; 21(1): 1206, 2021 Nov 12.
Article
in En
| MEDLINE
| ID: mdl-34772353
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pancreatic Neoplasms
/
Antineoplastic Combined Chemotherapy Protocols
/
Neuroendocrine Tumors
/
Angiogenesis Inhibitors
/
Dacarbazine
/
Antibodies, Monoclonal, Humanized
/
Antineoplastic Agents
Type of study:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Humans
/
Middle aged
Language:
En
Journal:
BMC Cancer
Journal subject:
NEOPLASIAS
Year:
2021
Type:
Article
Affiliation country:
Germany